The role of programmed cell death 1 (PD-1) and PD-1 ligand 1 (PD-L1) in the immune escape of cancer cells makes them promising targets of cancer therapy (Ghahremanloo et al., 2019; Akin Telli et al., 2020). Here, PDCD1 is linked to cancer.